H. Tamiaki et al./Bioorg. Med. Chem. 6 (1998) 2171±2178
2177
16 Hz, 131-CH2), 4.67 (1H, dq, J=2, 7 Hz, 18-H), 4.50
(1H, dt, J=9, 2 Hz, 17-H), 4.09 (2H, m, 13-CH2), 3.88
(2H, q, J=8 Hz, 8-CH2), 3.60, 3.58, 3.52, 3.45 (each
3H, s, 2-, 7-, 12-CH3, COOCH3), 2.76±2.87, 2.53±2.68,
2.32±2.45, 2.13±2.28 (each 1H, m, 17-CH2CH2), 2.23
(3H, d, J=7 Hz, 31-CH3), 1.86/1.84 (3H, d, J=7 Hz, 18-
CH3), 1.77 (3H, t, J=8 Hz, 81-CH3), 3.45 (1H, s, NH
(another NH was too broad to be observed)). MS
(FAB) found: m/z 552. Calcd for C34H40N4O3: M+,
552.
66.21, H; 6.04, N; 8.83. Calcd for C34H36N4O3Zn: C;
66.50, H; 5.91, N; 9.12.
Synthesis of zinc methyl 3-acetyl-3-devinyl-
pyropheophorbide-a (4)
Methyl bacteriopheophorbide-d10,19 was oxidized by
Pr4RuO4 Me(O)N(CH2CH2)2O in CH2Cl211 to give the
3-acetyl compound as a black solid in 75% yield (5%
Et2O±CH2Cl2 for FCC); mp 264±267 ꢀC (lit.20 264±
265 ꢀC); VIS (CH2Cl2) lmax=683 (rel. 52), 623 (7.4), 547
(11), 514 (12), 417 (100), 384 (79) nm; 1H NMR (CDCl3)
d=10.00, 9.61, 8.78 (each 1H, s, 5-,10-, 20-H), 5.34, 5.18
(each 1H, d, J=20 Hz, 131-CH2), 4.56 (1H, dq, J=2,
7 Hz, 18-H), 4.37 (1H, dt, J=9, 2 Hz, 17-H), 3.73 (2H,
q, J=8 Hz, 8-CH2), 3.72, 3.66, 3.61, 3.30
(3H+3H+3H+6H, s, 2-, 31-, 7-, 12-CH3, COOCH3),
2.54±2.78, 2.25±2.37 (each 2H, m, 17-CH2CH2), 1.84
(3H, d, J=7 Hz, 18-CH3), 1.72 (3H, t, J=8 Hz, 81-
CH3), 1.75 (1H, br, NH (another NH was too broad
to be observed)). MS (FAB) found: m/z 564. Calcd for
C34H36N4O4: M+, 564.
The above 31-hydroxy compound was oxidized to give
3-acetyl compound as a black solid in 71% yield (1%
Et2O±CH2Cl2 for FCC); mp 221±225 ꢀC; VIS (CH2Cl2)
l
max=657 (rel. 27), 603 (4.0), 544 (3.9), 508 (11), 411
1
(100) nm; H NMR(CDCl3) d=10.42, 9.47, 8.98 (each
1H, s, 5-, 10-, 20-H), 4.91, 4.79 (each 1H, ddd, J=3, 7,
16 Hz, 131-CH2), 4.62 (1H, dq, J=2, 7 Hz, 18-H), 4.46
(1H, dt, J=7, 2 Hz, 17-H), 4.05 (2H, m, 13-CH2), 3.82
(2H, q, J=8 Hz, 8-CH2), 3.76, 3.59, 3.47, 3.42, 3.36
(each 3H, s, 2-, 31-, 7-, 12-CH3, COOCH3), 2.73±2.84,
2.57±2.67, 2.17±2.40 (1H+1H+2H, m, 17-CH2CH2),
1.84 (3H, d, J=7 Hz, 18-CH3), 1.84, (3H, d, J=7 Hz, 18-
CH3), 1.75 (3H, t, J=8 Hz, 81-CH3), 2.89 (1H, br, NH
(another NH was too broad to be observed)). MS (FAB)
found: m/z 550. Calcd for C34H38N4O3: M+, 550.
The above metal-free compound was zinc-metallated for
2 h to give the title compound as green crystals in 95%
yield; mp 137±140 ꢀC; VIS (C6H6) lmax=672 (e, 51900),
620 (7300), 569 (4000), 526 (2760), 432 (68000), 384
(31400, sh) nm and (CH2Cl2) lmax=669 (rel. 73), 618
(11), 568 (6.0), 525 (3.7), 429 (100), 404 (66, sh), 380 (54,
The above metal-free compound was zinc-metallated for
1.5 h to give the title compound as metallic purple crys-
tals in 84% yield; mp 132±135 ꢀC; VIS (C6H6)
sh) nm; IR (KBr) 1736 (172-COO), 1668 (3/13-C=O),
1
lmax=641 (e, 46200), 596 (6100), 515 (5300), 514 (5400,
1615 (C=C) cm
;
1H NMR (CDCl3) d=9.44, 8.93,
sh), 414 (123000), 382 (28300, sh) nm and (CH2Cl2)
lmax=639 (rel. 25), 595 (4.7, sh), 550 (1.4, sh), 511 (6.3),
8.52 (each 1H, s, 5-,10-, 20-H), 4.90, 4.87 (each 1H, d,
J=20 Hz, 131-CH2), 4.49 (1H, dq, J=2, 7 Hz, 18-H),
4.28 (1H, dt, J=8, 2 Hz, 17-H), 3.65 (2H, q, J=8 Hz, 8-
CH2), 3.54, 3.37, 3.25, 3.02, 2.70 (each 3H, s, 2-, 31-, 7-,
12-CH3, COOCH3), 2.42±2.61, 2.13±2.36 (each 2H, m,
17-CH2CH2), 1.87 (3H, d, J=7 Hz, 18-CH3), 1.67 (3H,
t, J=8 Hz, 81-CH3). MS (FAB) found: m/z 626. Calcd
for C34H34N4O64Zn: M+, 626. Anal found: C; 64.40, H;
411 (100) nm; IR (KBr) 1736/1712 (172-COO), 1649 (3-
1
C=O), 1616 (C=C) cm 1; H NMR (CDCl3) d=9.89,
9.38, 8.77 (each 1H, s, 5-, 10-, 20-H), 4.75, 4.65 (each
1H, dt, J=16, 6 Hz, 131-CH2), 4.58 (1H, dq, J=2, 7 Hz,
18-H), 4.41 (1H, dt, J=7, 2 Hz, 17-H), 3.91 (2H, m, 13-
CH2), 3.76 (2H, q, J=8 Hz, 8-CH2), 3.55, 3.53 3.40,
3.26, 3.05 (each 3H, s, 2-, 31-, 7-, 12-CH3, COOCH3),
2.66±2.78, 2.53±2.63, 2.32±2.42, 2.18±2.27 (each 1H, m,
17-CH2CH2), 1.86 (3H, d, J=7 Hz, 18-CH3), 1.71 (3H,
t, J=8 Hz, 81-CH3). MS (FAB) found: m/z 612. Calcd
for C34H36N4O364Zn: M+, 612. Anal found: C; 60.00,
.
5.45, N; 8.87. Calcd for C34H34N4O4Zn 1/2H2O: C;
64.10, H; 5.54, N; 8.79.
Synthesis of zinc methyl bacteriopyropheophorbide-a (5)
Methyl bacteriopyropheophorbide-a (8, 20 mg)11 was
zinc-metallated in re¯uxing CHCl3 (10 mL) and MeOH
.
H; 5.35, N; 7.98. Calcd for C34H36N4O3Zn CH2Cl2: C;
60.10, H; 5.48, N; 8.01.
.
saturated with Zn(OAc)2 2H2O (10 mL) for 3 h (no
metallation occurred by stirring at room temperature as
described above) to give the title compound as a dark
blue solid in 66% yield; mp 193±196 ꢀC; VIS (C6H6)
lmax=774 (e, 144000), 706 (12400, sh), 561 (28800), 435
(4450, sh), 394 (62700), 356 (95200) nm and (CH2Cl2)
Synthesis of zinc methyl mesopyropheophorbide-a (3)
Methyl mesopyropheophorbide-a16 was zinc-metallated
for 1.5 h to give the title compound as purple crystals in
76% yield; mp 144±147 ꢀC (lit.4 144±148 ꢀC); VIS
(C6H6) lmax=645 (e, 76100), 599 (9410), 551 (3250), 423
(96300), 402 (60200), 380 (30400, sh) nm; see ref. 4 for
IR and 1H NMR data. MS (FAB) found: m/z 612.
Calcd for C34H36N4O364Zn: M+, 612. Anal found: C;
l
max=771 (rel. 100), 700 (13, sh), 553 (27), 433 (9.3, sh),
391 (58), 351 (91) nm; IR (KBr) 1736 (172-COO), 1650
1
;
1H NMR (CDCl3)
(3/13-C=O), 1604 (C=C) cm
d=8.82, 8.41, 8.26 (each 1H, s, 5-,10-, 20-H), 5.03, 4.88